Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Injury to Other Diseases Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Injury to Other Diseases Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Injury Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profile Snapshots 29
Appendix 146
Abbreviations 146
Definitions 146
Research Methodology 147
Secondary Research 147
About GlobalData 148
Contact Us 148
Source 148

List of Tables
Injury Therapeutics, Global, Clinical Trials by Region, 2017* 6
Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 9
Injury Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
Injury Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 12
Injury Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 13
Proportion of Injury to Other Diseases Clinical Trials, G7 Countries (%), 2017* 14
Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Injury to Other Diseases Clinical Trials, E7 Countries (%), 2017* 17
Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
Injury Therapeutics, Global, Clinical Trials by Phase, 2017* 20
Injury Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 21
Injury Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
Injury Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 25
Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28

List of Figures
Injury Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 9
Injury Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
Injury Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11
Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 12
Injury Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 13
Proportion of Injury to Other Diseases Clinical Trials, G7 Countries (%), 2017* 14
Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Injury to Other Diseases Clinical Trials, E7 Countries (%), 2017* 17
Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
Injury Therapeutics, Global, Clinical Trials by Phase (%), 2017* 20
Injury Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 21
Injury Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
Injury Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 25
Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28
GlobalData Methodology 147

Companies Mentioned
- Fresenius SE & Co KGaA
- Vivatech International Inc
- Pfizer Inc
- Orion Corporation
- Novartis AG
- Imprimis Pharmaceuticals Inc
- Epifarma Srl
- Eagle Pharmaceuticals Inc
- E. Merck KG
- Cato Holding Company